Senior insider sale
SAREPTA THERAPEUTICS, INC. — senior position signals high conviction
$1.93M
15K shares
What this filing means
WIGZELL HANS LENNART RUDOLF plans to sell 15K shares of SAREPTA THERAPEUTICS, INC. valued at approximately $1.93M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/8/2024ACC: 0001972362-24-000374
Director
Since Nov 2018
15K
Shares to sell
$1.93M
Approx. market value
15K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
STOCK OPTION EXERCISE
COMPENSATION
3/8/2024
15KTotal acquired15K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/8/2024 | STOCK OPTION EXERCISE COMPENSATION | 15K | — |
| Total | 15K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
15K
Market value
$1.93M
3/8/2024
Total
Units
15K
Value
$1.93M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
3/8/2024 | 15K | $1.93M | NASDAQ | Planned |
| Total | 15K | $1.93M | ||